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Damage to the microvasculature occurs commonly in au-
toimmune diseases affecting the skin. There has been little 
investigation of immune mechanisms other than immune 
complex deposition as a major cause of microvascular dam-
age. We have investigated the potential of antibody-de-
pendent cellular cytotoxicity (ADCC) to cause vascular 
destruction in an in vitro model consisting of human der-
mal microvascular endothelial cells to which were added 
antibody and leukocytes. Severe damage was induced by 
D amage to the dermal microvasculature is a promi-nent feature of human autoimmune diseases, such as systemic lupus erythematosus (SLE) and vascu-litis, that commonly affect the skin. Immune com-plex deposition with complement activation fol-
lowed by phagocyte chemotaxis and activation is believed to be 
the mechanism by which these lesions are caused [1,2]. 
It is , however, likely that mechanisms other than those in-
volving immune complexes may be important in the etiology of 
vascular damage. For example, dermal vascular damage may oc-
cur without any histologic evidence of inllTlUne complex depo-
sition [3,4] and may be characterized by perivascular collections 
oflymphocytes rather than the neutrophils usually associated with 
immune complex lesions [5]. In addition, lymphocytes have been 
able to be directly sensitized against vascular endothelium and 
w hen introduced in vivo caused vascular damage in multiple or-
gans [6]. There is also evidence from in vitro models that suggests 
the cytotoxic mechanism antibody-dependent cellular cytotox-
icity (ADCC) l11.ay be involved in the pathogenesis of human 
diseases with autoimmune features [7,8], and it has been suggested 
that ADCC may be able to mediate vascular destruction [5] . 
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Abbreviations: 
ADCC: antibody-dependent cellular cytotoxicity 
E:T: effector to target 
HBSS: Hanks' balanced salt solution 
HBSS-BSA: Hanks' balanced salt solution with calcium and 
magnesium containing 1 % bovine serum albumin 
K: killer 
M199H: Medium 199 with 25 111M HEPES buffer 
NK: natural killer 
PBS: phosphate-buffered saline 
PMA: phorbol-l11yristate acetate 
SLE: systemic lupus erythematosus 
antibody and lymphocytes. Monocytes or neutrophils were 
not able to mediate cytotoxicity although activated neu-
trophils caused endothelial detachment. The cytotoxic cells 
were OKT3 - , Leu 11 + and were identified as K cells. 
ADCC was not inhibited by human serum or aggregated 
IgG. These results imply that ADCC may have a role in 
causing the vascular destruction observed in some human 
autoimmune skin diseases . J Inllest D ermatol 87:519-523, 
1986 
We studied the potential of ADCC to cause dermal microvas-
cular destruction by constructing an in vitro model consisting of 
tissue cultures of human dermal microvascular e.ndothelial cells 
and peripheral blood cells. It was found that ADCC induced 
severe endothelial injury, and the investigation of this cytotoxic 
system forms the subject of this report. 
MA TERIALS AND METHODS 
Unless otherwise stated all tissue culture media and additives w~re 
obtained from Flow Laboratories (Ayrshire, Scotland) , tissue c'ul-
ture and other disposables from Corning, and analytical gr~de 
chemicals and other compounds from the Sigma Chemical Com-
pany or Ajax Chemicals (Sydney, Australia) . 
Peripheral Blood Leukocytes Blood was collected from healthy 
laboratory personnel and anticoagulated with 0.5% sodium ci-
trate . Mononuclear cells were isolated on a Ficoll-Paque discon-
tinuollS density gradient (Pharmacia Fine Chemicals) . Neutro-
phils were separated from the erythrocyte pellet by resuspending 
it in 3% dextran followed by sedimentation at 1 g and 37°C for 
20 min. The neutrophil-rich supernatant was freed of erythrocytes 
by two 20-s cycles of hypotonic lysis with phosphate-buffered 
saline (PBS) diluted 1:9 in water. Both cell preparations were 
typically more than 98% viable as assessed by try pan blue dye 
exclusion and less than 5% contaminated by other cell types. Cells 
were washed twice with Hanks ' balanced salt solution (HBSS) 
without calcium or magnesium and suspended for use in M19?H 
(Medium 199 with 25 mM HEPES buffer) . 
Lymphocyte and Monocyte Separation by Centrifugal Elu-
triation Mononuclear cells were separated into lymphocyte and 
monocyte populations by centrifugal elutriation using a Beckman 
JE-6B e1utriation system and rotor [9]. The cells were collected 
in 5 fractions; fractions 2 and 4 contained cells enriched for lym-
phocytes and monocytes, respectively . Differential cell counts 
were performed on cytocentrifuged preparations after air drying 
and Giemsa staining. 
Monoclonal Antibody Staining, Flow Cytometry, and 
Sorting In order to facilitate flow cytometry, the mononuclear 
cell preparation was depleted of platelets , monocytes, and B lym-
phocytes by adherence to a nylon wool column [10]. The resultant 
population of lymphocytes was stained with fluorescein-conju-
gated monoclonal antibodies OKT3 (Ortho Diagnostics, New 
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Jersey, U .S. A.) or Leu 11 (Becton Dickinson, Califo rnia, U .S. A.) 
fo r 20 min at 4°C following which they were washed twice, 
resuspended in PBS, and kept at 4°C until used. Cell sorting w as 
done in a Coulter Epics V fl ow cytometer equipped w ith a Spec-
traphysics 164-05 laser operated at 488 nm and an output of 400 
m W . Cells were gated for sorting on the basis o f flu o rescence 
and the forward angle light scatter signal. 
Serum and Culture Medium Blood w as collected and pooled 
fro m several healthy laboratory personnel into 50-ml plas tic cen-
trifuge tubes, clotted at 37°C for 1 h, and the clo t retracted at 
4°C fo r 1 h. The cells were removed by centrifuga tion and the 
serum stored at - 20°C until used. Serum utilized in an attempt 
to inhibit ADCC was isolated immediately befo re use and was 
not frozen. Culture medium consisted of 50% human serum in 
Medium 199 containing vancomycin 100 mg/li ter, amphotericin 
2.5 mglliter, genta micin 50 m g/liter, and HEPES buffer 25 mM. 
Aggregated IgG Im munoglobulin G w as heat aggregated [11], 
separated fro m residual monomeric IgG ' by precipi tation with 
3.5% polyethylene glycol [1 2], and had its pro tein concentration 
determined before storage at - 20°C. The aggregates were tested 
fo r immune complex activi ty by their capacity to bind radiola-
beled Cl q [1 3]. Aggregated IgG at concentrations of125 mg/liter 
and 12.5 mg/liter caused C 1 q binding, respectively , o f 40% and 
25% (normal sera r ange fo r binding, 0-1 2%). 
C ell Activators Boiled zymosan was opsonized in fresh human 
serum at a concentra tion of 10 g/li ter fo r 1 h at 37°C in' a shaking 
water ba th. T he zym osan w as washed tw ice in PBS, resuspended 
in M199H, and used at a final concentration of 5 g/liter. Pho rbol-
myristate acetate (PMA) w as dissolved in DMSO at 1 g/ li te r, 
diluted in M 199H , and used at a fin al concentration of 10- 7 M. 
O psonized zymosan and PMA were confi rmed as active in the 
concentrations used by their capacity to induce a chemilumines-
cent response in neutrophils and m onocytes. 
Antibody for Inducing ADCC T he antibody used in these 
studies was a rabbit IgG antihuman B2-microglobulin (Dakopatts, 
Glos trup, Denmark). It was shown to bind to cultured endothelial 
cells by positive indirect immunoflu orescence. T he antibody w as 
used at a dilution of 1:100 unless o therwise stated. N ormal rabbit 
serum was used as a control for the antibody. 
Endothelial C ells Endo thelial cells w ere extracted and grown 
fro m human neonatal fores kins as described [14]. Endotheli al 
identity w as confirmed by positive immunofluo rescence for Fac-
tor VIII antigen, by the typical m orphology of confluent cultu res 
and the presence of Weibel-Palade bodies. 
Cytotox icity A ssay Endothelial cytotoxicity was assessed in 
96-well flat- bottom tissue culture plates. T he wells were pre-
coated with 50 f.l-l of fi bronectin (10 mg/liter) w hich was aspirated 
after 10 min. Endo thelial cells (1 0,000- 20,000) w ere added to each 
well in 100 f.l-l of cultu re medium containing 2 X 10- 3 giga-
Becquerels of N a51C r04 (A mersham , U .K. ). Greater than 85% 
of the cells would attach to the culture surface overnight. T he 
next day attached cell s were gently washed 5 times w ith HBSS-
BSA and left fo r 2 h in fresh culture medium . At the end of this 
time the cells were washed twice w ith H BSS-BSA and the effector 
cells added in a total volume of 150 J.Ll o f M199H . An effecto r 
to targe t (E:T) cell ra tio of 50: 1 was used unless otherwise stated. 
In experiments where antibody w as used in conjunction with 
effector cells it was added to the target cells in M1 99H and in-
cubated fo r 20 min at room temperature, then aspirated and the 
effector cells added. 
Effector cells were usually incubated wi th the endo thelial tar-
gets fo r 4 h at 37°C. At the end of this period the contents of 
each well were aspirated and pooled w ith 2 further gentle wash-
ings of 100 f.l-l each (tube a). T hese pooled washings were cen-
trifuged at 200 g for 10 min and the top half of the supernatant 
removed from tube a and transferred to ano ther tube (tube b) . 
T he cells rem aining in the mjcrowells were removed with 100 f.l-l 
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of 0.05% trypsin and 0.02% EDTA and transferred to a third 
tube (tube c). It was found that trypsin-EDT A rem oved signif-
icantly more radioactivity from the culture wells than either d e-
tergent trea tment with 0.1 % T riton X-lOO or freeze-thawing. 
The volumes in the tubes were equalized and the tubes counted 
in a Packard PRiAS gamma counter fo r 1 min . Da ta were ex-
pressed as percent C r release calculated as 200 x b/ (a + b + c) 
and percent detached cells calculated as 100 x (a - b) / (a + b + 
c). All experimental conditions were performed in triplica te an d 
the results reported as the mean of these 3 readin gs. If 2 x SE 
was g rea ter than 1 % it was also reported alld represented in fi gures 
by error bars. 
RE SULTS 
Antibody-Dependent Cellular Cytotoxicity Induced b y 
Mononuclear Cells The effect of adding a m ononuclear cell 
prepara tion to the endo thelial cell s is shown in Table I. In the 
absence of antibody, mononuclear cells w ere able to induce only 
a sm all increase in C r release. Antibody pretrea tment of endo -
thelial cells led to m arked m ononuclea r cell-mediated damage. 
The endothelial cell damage was antibody-specific as substituting 
no rmal rabbit serum fo r antibody was not associated with cy-
totoxicity (res ults no t shown) . There w as also so me evidence of 
endothelial detachment accompanying the ADCC but it w as much 
less than the actu al C r release. 
T he parameters of the cyto toxic system were inves tigated by 
following the time course of the dam age and titrating the antibo dy 
and the effecto r cells. T he results are shown in Figs 1-3. 
Mononuclear Cell-Induced ADCC Is Due to Lymphocytes 
A mononuclea r cell preparation w as separated by centrifugal elu-
triation into populations enriched for n1.onocytes (monocytes 75%, 
lymphocytes 15%, neutrophils 3%, unidentified cells 7% ) and 
lymphocytes (lymphocytes 83%, monocy tes 17% ). T hese prep-
arations as well as neutrophils were tested fo r their abili ty to 
induce ADCC over a range of E:T cell ratios. T he results are 
shown in Fig 4. C hromium release induced by the lymphocytes 
very closely resembled C r release induced by the whole m ono-
nuclea r cell prepara tion except that the lymphocytes were m ore 
poten t at the lowest E:T cell ratio . M onocytes did not cause any 
C r release except at the larges t E:T cell ra tio , probably due to the 
15% lymphocytes contaminating the monocyte preparation . 
Antibody-Dependent Cellular Toxicity of Lymphocyte 
Subpopulations Further attempts were made to isolate the cell 
population responsible for the ADCC by identifyin g subpopu-
lations of lymphocytes w ith monoclonal antibodies , separating 
positively and negatively stained lymphocytes by fl ow cytom etry, 
and cell sortin g and using them as effector cells. 
The results of tes ting O KT3-positive and -negative staining 
lymphocytes fo r ADCC are shown in T able II. C hromium release 
was largely associated with the OKT3-negative population , su g-
Table I. Direct and Antibody-D ependent Cellular 
Cytotoxicity of Endo thelial Cells Induced by a Mononuclear 
Cell Preparation 
Antibody 
+ 
+ 
+ 
+ 
Additive 
Nil 
Zymosan 
Mononuclears" 
Mononuclea rs + zymosan 
Nil 
Zy mosan 
Mononuclears 
Mononuclears + zymosan 
Percent 
Percent Detached 
Cr Release Cells 
8 1 
8 2 
10 1 
13 
9 1 
8 2 
68 ::': 5 7 ::': 6 
66 ::': 2 8 ::': 3 
' Mononu clear cells were used at an effector to target cell ratio o f 100:1. 
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Figure 1. Effect of incubation time on ADCC of endothelial cells. Per-
cent Cr release was measured after incubating endothelial cells with an-
tibody for 20 min fo llowed by mononuclea r cells for va rying times. 
Spontaneous C r release (doff ed IiI/e), C r release induced by ADCC (d"shcd 
/in e) , difference between ADCC and spontaneous C r release (so lid IiI/e). 
Error bars represent ± 2 SEM. 
ges ting that the cell mediatin g the ADCC was no t a T cell . Con-
trols demonstrated that cells stained with antibody and passed 
through the flow cytometer retained the capacity to mediate ADCC. 
Res ults not shown indicate that staining lymphocytes with OKT3 
was not able to substitu te for the antiendothelial antibody in 
inducing ADCC. 
The resu lts of testing Leu ll -positive and -negative stainin g 
lymphocytes for ADCC are shown in Table III . T he ADCC 
activi ty was entirely associated w ith the Leu ll-positive fraction. 
The controls were the sa me as for OKT3. 
Failure to Inhibit ADCC with Serum or Aggregated IgG 
Increasing concentrations of human serum or heat-aggrega ted 
fgG were added with mononuclea r cells to antibody-treated endo-
thelial cells to determine w hether they could inhibi t ADCC. T he 
anti body was used at a suboptimal dilution of 1:10,000 in order 
to fac ilitate any inhibitory influence of the add itives. T he results 
are shown in Fig 5 and demonstrate that neither reagent was 
inhibitory . Results not shown demonstrate that 75% of human 
serum or 100 ILg/ml of aggregated IgG had no effect on C r release 
from antibody-trea ted endo thelial cells in the absence of mono-
nuclear cells. 
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Figure 2. Effect of antibody dilu tion on ADCC of endothel ia l cell s. 
Percent Cr releasc was mcasured after incubating endothelia l cell s with 
varying dilu tions of antibody fo llowed by mononuclear cell s. Error bars 
represent ± 2 SEM . 
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Figure 3. Effect of E:T ce ll ratio on ADCC of endothelial ce lls. Percent 
C r releasc was measured after incubating endothelia l cells with antibody 
fo llowed by vary ing numbers of mononuclear cell s. Error bars reprcsent 
± 2 SEM . 
Failure of Neutrophils to Induce Cytotoxicity Attempts 
were made to induce endothelial damage with zy mosan-activated 
neutrophils in the sa me way as had been done w ith mononuclear 
cells. N eutrophils were not able to ca use any increase in Cr release 
either directl y or by ADCC (resul ts not shown). As it has been 
suggested that zym osan may inhibit rather than induce phago-
cyte-mediated endothelial damage [15), the experi ment was re-
peated , with the nonparticulate stimulus PMA used as the phago-
cytic activator; however the results were the sam e. Activated 
neut rophils were, however, able to induce detachment of endo-
thel ial cells from the culture surface, increasing from 1 % for 
untrea ted endothelium to 8( ± 2)% for endothelium exposed to 
zy mosan-activa ted neutrophils. Antibody did not affect these re-
sults. Medium 199 contains amino acids, so me of w hich are ca-
pable of scavenging the oxidants that mediate neutrophil cyto-
toxicity. However repeated experiments performed llsing HBSS 
as an alternative to M 199H fa iled to demonstrate neutrophil-
m ediated endothelial cytotoxicity. 
DISCUSSIO N 
Endothelial cells derived fro m large blood vessels such as the 
umbilical vei n are easily cultured and have been very w idely used 
to study vascular physiology and pathology. However the en-
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Figure 4. Antibody-dependent cellular cytotoxicity of endothelial cel ls 
ca used by different ce ll popu lations at a range of E:T cell ratios. Endo-
thelial cells were incubated with antibody fo llowed by varying numbers 
of different effector cell s. Neutrophils (dashed/dol/ed line), lymphocytes 
(so lid /iI/ e), mononuclear cel ls (dol/ed IiI/e), monocytes (dashed IiI/ e). Error 
bars represent ± 2 SEM. 
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Table II. Endothelial Cytotoxicity Induced by Lymphocytes 
Separated by Flow Cytometry and Sorting on the Basis of 
Staining with the Monoclonal Antibody OKT3 
Effector Cells Added' 
Nil 
Lymphocytes (unstained, cytometer run)b 
Lymphocytes (OKT3 stained, cytometer run)' 
OKT3-positive sorted lymphocytes,i 
OKT3-negative sorted lymphocytes' 
"Lymphocytes were used at an effector to target ceIl ratio of 15: 1. 
Percent 
Cr Release 
13 
59 ± 2 
48 ± 4 
23 ± 3 
73 ± 3 
bLy mphocytes passed through the flow cy tometer but otherwise untreated. 
'Lymphocytes sta ined with antibody to OKT3 and passed through the flow cy-
tometer but collected in one sample without any attempt to separate positive- from 
ne¥.ative-staining cells. 
Lymphocy tes sorted on the basis of positive staining for OKT3. 
' Lymphocytes sorted on the basis of negative staining for OKT3. 
dothelium is a heterogeneous tissue with major differences be-
tween endothelium of large and small blood vessels [16,17] . Hu-
~an microvascular endothelial cells were used in this study because 
mflammatory and immune vascular damage occurs far more com-
monly in the microvasculature than in large vessels. There is also 
evidence that suggests that important organ-specific differences 
may exist between different microvascular beds [18,19]. There-
fore endothelial cells derived from the dermis were utilized as the 
skin is a common site for immune vascular damage . . 
ADCC was first described by Moller in 1965 [20] and since 
that tim~ has been shown to be capable of being mediated by 
several different effector cell types . For a cell to function in ADCC 
it is nece.ssary that it possess cytotoxic capacity and an Fc receptor 
for bmdmg to the antibody-coated target cell. Of the cells in the 
peripheral blood these requirements are fulfilled by monocytes, 
polymorphonuclear leukocytes, and killer (K) cell s [21]. However 
the cells mediating ADCC in this experimental system were re-
stricted to the subpopulation of lymphocytes known as K cells 
[22], a lineage oflymphocytes distinct from T and B cells [23,24]. 
It has been shown that ADCC is capable of killing a large range 
of target cells [25] including keratinocytes [26] and umbilical vein 
endothelial cells [27], although cytotoxicity for microvascular 
endothelial cells has not previously been demonstrated. 
The antibody Leu 11 was used to separate the lymphocytes 
beCause it identifies all the lymphocytes in the peripheral blood 
that have K cell activity and does not identify T cells or B cells 
[28,29]. Leu 11 inhibited the endothelial cytotoxicity observed by 
20%, possibly because it interfered with the binding of the Fc 
reGeptor on the K cell to the antibody on the endothelial cell . As 
expected, all the ADCC was found in the Leu ll-positive pop-
ulation and none at all in the Leu 11-negative population. OKT3 
was used to separate T cells [30] and most of the ADCC was 
Table III. Endothelial Cytotoxicity Induced by Lymphocytes 
Separated by Flow Cytometry and Sorting on the Basis of 
Staining with the Monoclonal Antibody Leu 11 
Effector Cells Added' 
Nil 
LYI:nphocytes (unstained, cytometer run)b 
LY~1phocytes (Leu 11 stained, cytometer run)' 
Leu 1l-positive sorted lymphocytes,i 
Leu It-negative sorted lymphocytes' 
Percent 
Cr Release 
15 ± 2 
53 ± 3 
43 ± 4 
64 ± 5 
13 
;Lymphocytes were used at an effector to target cell ratio of 15:1. 
, Lymphocytes passed through the flow cytometer but otherwise untreated . 
Lymphocytes stained with antibody to Leu 11 and passed through the flow 
cytometer but coll~cted in one sample without any attempt to separate positive-
from ncgauvc-stallung cells. 
' Lymphocytes sorted on the basis of positive staining for Leu 11. 
'Lymphocytes sorted on the basis of negative staining for Leu 11. 
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Figure 5. Effect of increasing concentrations of aggregated IgG and hu-
man serum on endothelIal ADCC. Endothelial ce lls were incubated with 
a 1:10,000 dilution of antIbody followed by mononuclear cells and either 
aggregated IgG or human serum . Human serum (so lid /ilie), aggregated 
IgG (dotted lirie). Error bars represent ± 2 SEM. 
identified in the OKT3~n.egative population. It was not surprising 
that there was some killing With the OKT3-positive population 
as ~ proportion of immature K cells are known to express the T3 
antigen [31] , reactivity diminishing as the cells develop. 
Rabbit anti-f32-microglobulin antibody was used to induce the 
ADCC. Rabbit antibody was used because human antibodies with 
reactivity for all human endothelial cells are not available. Rabbit 
immunoglobulin has been w idely used to investigate antibody 
interactions with human immune cell s and has been shown to 
occupy. the same bindin.g site as hu.man immunoglobulin [32]. 
In spite of the extensIve deSCrIptIons of ADCC in vitro there 
is only relatively limited information suggesting a role for ADCC 
as a cause of in vivo human pathology [7 ,8,27,33]. The dem-
onstration of ADCC against endothelial cells in vitro raises ques-
tions as to the significance of this phenomenon as a cause of human 
vascular Immunopathology. Binding of the Fc region of an an-
tlbod'y to the Fcreceptor on a cytotoxic cell may be competitively 
mhlblted by flllld phase Immune complexes, and the OCCllrrence 
of this phenomenon has been used to argue against the relevance 
o.f ADC.C to human patholo~y [34,35). However it was not pos-
Sible to mhlblt the ADCC With increasing concentrations of hu-
man serum or of aggregated IgG even using a limiting concen-
tration of endothelial antibody. Thus for at least some concentrations 
of tarl?et ~ell .antibody and immune complex, ADCC may be 
operatIve 111 VIVO. 
Further evidence for the possible involvement of lymphocyte-
mediated ADCC in human pathology has come from our recent 
(unpubli.shed)o studies: Ly.mpl~ocytes with the K phenotype are 
present m 35 Yo of skill biopSies from patients with progressive 
systemI.c sclerosis and in addition 19% of these patients have a 
clrculatmg antibody that will nl.ediate ADCC against human der-
mal microvascular endothelial cells. 
The authors thm'ik Dr. K. Hopper Jor pe/forlilillg the celltrijilgal eilltriatioll alld 
Dr. G. V. Chapl1la" Jor performillg the flow cytoliletry and sortilig. 
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